证券代码：002858 证券简称：力盛体育 公告编号：2025-044 力盛云动（上海）体育科技股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 《中华人民共和国证券法》 《上市公司证券发 行注册管理办法》等有关法律、法规和规范性文件的规定，鉴于公司对本次向特 定对象发行股票投资项目经济效益测算进行了调整，就本次向特定对象发行 A 股股票事项编制了《力盛云动（上海）体育科技股份有限公司 2023 年度向特定 对象发行 A 股股票预案（四次修订稿）》。 表决结果：同意 3 票、反对 0 票、弃权 0 票。 具体内容详见同日披露于《中国证券报》《上海证券报》《证券时报》《证券 日报》及巨潮资讯网（http://www.cninfo.com.cn）《关于公司 2023 年度向特定对 象发行 A 股股票预案修订情况说明的公告》。 一、会议召开情况 力盛云动（上海）体育科技股份有限公司（以下简称"公司"）第五届监事 会第九次会议于 2025 年 5 月 30 日在上海市长宁区福泉北路 518 号 8 座 2 楼公 司会议室以通讯方式召开，会议通知及相关材料于 ...

Core Viewpoint - Youon Technology Co., Ltd. plans to issue up to 71,819,411 shares of RMB ordinary stock (A shares) to specific investors, with China International Capital Corporation (CICC) acting as the sponsor for this issuance [1][16]. Group 1: Issuance Details - The issuance will involve a total of 71,819,411 shares, which includes the shares being issued [1]. - The company has complied with relevant laws and regulations, including the Company Law and Securities Law, in preparing for this issuance [1][19]. - The issuance is intended for specific investors and will not be conducted through public solicitation [19]. Group 2: Company Overview - Youon Technology Co., Ltd. was established on August 24, 2010, and is registered in Changzhou, Jiangsu Province [1]. - The company specializes in the development, manufacturing, integration, installation, debugging, sales, and information technology services related to public bicycle systems [1][2]. - The company also engages in the development and sales of various electronic devices, including electric bicycles and artificial intelligence equipment [2]. Group 3: Financial Performance - As of March 31, 2025, the company's total assets were RMB 436,379.52 million, with total liabilities of RMB 120,974.70 million, resulting in shareholders' equity of RMB 315,404.82 million [3]. - The company's revenue for the first quarter of 2025 was RMB 8,339.92 million, while the operating profit was a loss of RMB 2,194.77 million [3][4]. - The net profit attributable to the parent company for the first quarter of 2025 was a loss of RMB 2,462.50 million [4]. Group 4: Shareholder Structure - As of April 30, 2025, the total share capital of the company was 240,601,181 shares, with the top ten shareholders holding significant portions of the equity [2]. - The largest shareholder, Youon Technology Co., Ltd., holds 57.65% of the total shares [2]. Group 5: Regulatory Compliance - CICC has conducted thorough due diligence and confirmed that Youon Technology meets the basic conditions for issuing A shares to specific investors [11][16]. - The company has followed the necessary decision-making procedures as required by law, including board meetings and shareholder approvals [17][18].

Core Viewpoint - The company has decided to terminate the plan for a specific issuance of A-shares for the year 2023 due to changes in the capital market environment and its own circumstances, while also preparing for a new issuance plan for 2025 [1][2]. Meeting Details - The fourth Supervisory Board's 20th meeting was held on May 30, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1]. Resolutions Passed - The resolution to terminate the 2023 specific issuance of A-shares was approved unanimously [2]. - The resolution confirming the company's eligibility for a specific issuance of A-shares was also approved unanimously [2]. - The resolution for the 2025 specific issuance of A-shares was approved, detailing the type of shares, issuance method, and timing [3][4]. Issuance Plan for 2025 - The shares to be issued will be domestic RMB ordinary shares (A-shares) with a par value of RMB 1.00 each [3]. - The issuance will be conducted through a specific issuance method, subject to approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [3]. - The issuance will target no more than 35 specific investors, including various financial institutions and qualified investors [3][4]. Pricing and Quantity - The issuance price will not be lower than 80% of the average trading price over the 20 trading days prior to the pricing date [4]. - The total number of shares issued will not exceed 30% of the company's total share capital before the issuance, amounting to a maximum of 67,043,169 shares [5]. Fundraising and Usage - The total amount to be raised from the issuance is capped at RMB 150 million, with the net proceeds intended for specific investment projects [6][9]. - The company may adjust the investment sequence and amounts based on project progress and funding needs [9]. Lock-up Period and Listing - Shares acquired through this issuance will be subject to a six-month lock-up period post-issuance [10]. - After the lock-up period, the shares will be listed on the Shanghai Stock Exchange [10]. Profit Distribution - The retained earnings prior to the issuance will be shared among new and existing shareholders based on their respective shareholding ratios post-issuance [10]. Validity of Resolutions - The resolutions related to the issuance are valid for 12 months from the date of approval by the shareholders' meeting [10]. Future Dividend Planning - The company has developed a three-year dividend return plan (2025-2027) to enhance its dividend decision-making and investor return mechanisms [15].

二、会议审议通过《关于公司 2024 年度向特定对象发行 A 股股票预案（修 订稿）的议案》。 股票简称：北方国际 股票代码：000065 公告编号：2025-057 北方国际合作股份有限公司 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 北方国际合作股份有限公司（以下简称"公司"或"北方国际"）九届六次 监事会会议于 2025 年 5 月 29 日以通讯会议表决的形式召开。由于相关议案需要 监事会尽快作出决议，为维护公司利益，会议通知于 2025 年 5 月 28 日以邮件方 式发送至全体监事，全体监事一致同意豁免本次会议通知时限。本次会议应参与 审议表决的监事 3 名，实际参与审议表决的监事 3 名，会议由监事会召集人李正 安主持。会议召开程序符合《中华人民共和国公司法》和《公司章程》的有关规 定，会议合法有效。经全体参会监事审议： 一、会议审议通过了《关于调整公司向特定对象发行 A 股股票方案的议案》。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 公司根据《中华人民共和国公司法》《中华人民共和国证券法》及《上市公 司证券发行注册管理办法》等相关 ...

Core Viewpoint - Tianyin Communication Holdings Co., Ltd. plans to issue A-shares to specific investors, which may dilute immediate returns for existing shareholders, but the company has committed to measures to compensate for this dilution [1][4][6]. Group 1: Impact Analysis of Share Issuance - The total amount to be raised from the issuance is 1,708 million yuan [1]. - The analysis of the impact on key financial indicators is based on three scenarios: net profit remaining flat, increasing by 10%, and decreasing by 10% compared to 2024 [1][2][3]. - In the scenario where net profit remains flat, the diluted earnings per share (EPS) would be 0.03 yuan, while the basic EPS would also be 0.03 yuan [2][3]. - In the scenario of a 10% increase in net profit, the diluted EPS would be 0.03 yuan, and the basic EPS would be 0.03 yuan [3]. - In the scenario of a 10% decrease in net profit, the diluted EPS would drop to 0.02 yuan, and the basic EPS would also be 0.02 yuan [3]. Group 2: Necessity and Reasonableness of the Issuance - The issuance is deemed necessary to support projects closely related to the company's main business, including marketing network construction and digital platform development [4][6]. - The projects are expected to enhance the company's market competitiveness and align with its strategic development goals [6][7]. Group 3: Measures to Mitigate Dilution Risk - The company plans to strengthen the management of raised funds to ensure they are used effectively and in compliance with regulations [5][7]. - It aims to ensure the timely progress of investment projects to maximize the efficiency of fund usage and achieve expected benefits quickly [7][8]. - The company will adhere to a strict cash dividend policy to enhance investor return mechanisms [8]. Group 4: Commitments from Management - The company's directors and senior management have committed to fulfilling their responsibilities diligently and protecting the interests of all shareholders [6][9]. - The controlling shareholder has also pledged not to interfere with the company's management and to protect its interests [6][9].

天音通信控股股份有限公司 经审议，我们认为公司编制的《天音通信控股股份有限公司 2023 年度向特 定对象发行 A 股股票的论证分析报告（四次修订稿）》符合《公司法》 《证券法》 《上市公司证券发行注册管理办法》等法律、法规和规范性文件的规定，不存在 损害公司及全体股东特别是中小股东利益的行为。我们一致同意该议案，并同意 将该议案提交公司第九届董事会第三十八次会议审议。 天音通信控股股份有限公司于 2025 年 5 月 27 日召开 2025 年第二次独立董 事专门会议，根据《中华人民共和国公司法》《上市公司独立董事管理办法》等 法律法规以及《公司章程》的有关规定，作为天音通信控股股份有限公司（以下 简称"公司"）独立董事，我们本着对公司、全体股东及投资者负责的态度，基 于独立判断的立场，对公司第九届董事会第三十八次会议相关事项进行了审议并 发表以下意见： 一、《关于调整公司 2023 年度向特定对象发行 A 股股票方案的议案》的审 核意见 经审议，我们认为本次对公司 2023 年度向特定对象发行 A 股股票方案中的 "募集资金规模和用途"的相关内容的调整符合《公司法》《证券法》《上市公 司证券发行注册管理办 ...

证券代码：300573 证券简称：兴齐眼药 公告编号：2025-021 沈阳兴齐眼药股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 过电子邮件等形式送达至各位董事，董事会会议通知中包括会议的相关资料，同 时列明了会议的召开时间、地点、内容和方式。 的方式召开。 本次董事会。 二、董事会会议审议情况 会议审议并通过了如下议案： （一）审议通过《关于公司符合向特定对象发行 A 股股票条件的议案》 根据《中华人民共和国公司法》 《中华人民共和国证券法》 《上市公司证券发 行注册管理办法》等有关法律法规的规定，对照上市公司向特定对象发行股票的 条件，董事会对公司的实际情况及相关事项进行认真的自查论证后，认为公司符 合向特定对象发行 A 股股票的资格和条件，同意公司申请本次向特定对象发行人 民币普通股（A 股）股票（以下简称"本次发行"）。 表决结果：9 票赞成，0 票反对，0 票弃权。 本议案已经公司董事会审计委员会、独立董事专门会议审议通过。尚需提交 股东大会审议。 律法规和《公司章程》的有关规定。 （二）审议通过《关于公司 2 ...

一、审议通过《关于公司符合向特定对象发行A股股票条件的议案》 经审议，独立董事认为，公司符合《中华人民共和国公司法》《中华人民共和国 证券法》《上市公司证券发行注册管理办法》等法律法规、规范性文件关于向特定对 象发行A股股票的有关规定，具备向特定对象发行A股股票的条件。 沈阳兴齐眼药股份有限公司 第五届董事会独立董事专门会议 2025 年第二次会议决议 沈阳兴齐眼药股份有限公司（以下简称"公司"）第五届董事会独立董事专门 会议 2025 年第二次会议通知于会议召开前 3 日以电子邮件的形式发出，会议于 2025 年5月27 日在公司会议室以现场与通讯会议相结合的方式召开。公司独立董事共 3 人， 出席本次会议的独立董事共 3 人，会议由独立董事徐先梅女士召集并主持。本次会 议的召开符合《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规 则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 及《沈阳兴齐眼药股份有限公司章程》（以下简称"《公司章程》"）等有关规定， 会议形成的决议合法、有效。与会独立董事经认真讨论，形成如下决议： 独立董事一致同意该议案，并同意将本议案提交公司 ...

Core Viewpoint - Fujian Guangshentang Pharmaceutical Co., Ltd. is preparing to issue A-shares to specific investors in 2025, with the aim of raising funds for various projects, including innovative drug research and traditional Chinese medicine industrialization. Group 1: Issuance Details - The company plans to issue no more than 47,780,100 A-shares, which will not exceed 30% of the total share capital before the issuance [12][14] - The total amount to be raised is not more than 976.87 million yuan, with funds allocated to innovative drug research, traditional Chinese medicine industrialization, and working capital [15] - The issuance will be conducted through a specific object issuance method, targeting up to 35 specific investors, including qualified institutional investors and natural persons [12][15] Group 2: Legal Compliance and Approval - The board of directors and the shareholders' meeting have approved the issuance plan, ensuring compliance with the Company Law and the company's articles of association [11][16] - The issuance is subject to approval from the Shenzhen Stock Exchange and registration by the China Securities Regulatory Commission [16][17] - The company has conducted thorough legal due diligence to ensure compliance with relevant laws and regulations [6][24] Group 3: Company Structure and Independence - Fujian Guangshentang Pharmaceutical is a legally established joint-stock company with independent operations, assets, and financial management [24][26] - The company has no business relationships with its controlling shareholders that would compromise its independence [25][26] - The controlling shareholder, Aohua Group, holds 17% of the shares, while the actual controllers have a combined voting power of 40.89% [27][28] Group 4: Financial and Operational Integrity - The company has maintained a clean legal record, with no significant violations or administrative penalties in the past three years [20][21] - The financial statements have been audited and comply with accounting standards, ensuring transparency and reliability [20][21] - The company has established a robust governance structure, with independent management and operational capabilities [25][26]

Core Viewpoint - The company plans to issue A-shares to specific investors, which will dilute immediate returns but includes measures to compensate for this dilution [1][4][8]. Financial Impact - The issuance will increase the total share capital from 137,514,200 shares to 178,768,460 shares [2][3]. - Three scenarios for net profit after non-recurring gains for 2025 are considered: a 10% increase, no change, and a 10% decrease compared to 2024 [1][2]. Issuance Necessity and Reasonableness - The total amount raised from the issuance will not exceed 640 million yuan, which will be invested in a project to produce 135,000 tons of DTY yarn and 120,000 tons of high-performance leather base fabric [4][5]. - The project aims to enhance production capacity and improve product quality, thereby increasing market share and competitiveness [6][7]. Project Relationship with Existing Business - The investment project is aligned with the company's current operations and aims to upgrade production capacity and extend the industrial chain [6][7]. - The project will allow the company to control product quality more effectively by shifting from external procurement to internal production of key raw materials [6][7]. Human Resources, Technology, and Market Readiness - The company has a strong team of experienced personnel in DTY yarn and fabric production, ensuring effective project implementation [6][7]. - The company possesses significant technological capabilities with numerous patents, which will support the successful execution of the project [7]. - The project is expected to have a positive market reception, with a substantial portion of production being absorbed internally, enhancing the company's market influence [7]. Measures to Mitigate Dilution of Immediate Returns - The company will strengthen the supervision of raised funds to ensure they are used effectively and legally [9]. - There will be an emphasis on accelerating project construction to enhance profitability and shareholder returns [9][10]. - The company will maintain and optimize its profit distribution system to reinforce investor return mechanisms [10]. Commitments to Ensure Implementation of Compensation Measures - The controlling shareholder and management have made commitments to ensure the effectiveness of measures to compensate for the dilution of immediate returns [11]. - These commitments include adherence to regulatory requirements and accountability for any losses incurred due to non-compliance [11].